A detailed history of Vest Gen Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Vest Gen Advisors, LLC holds 4,598 shares of NVO stock, worth $222,819. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,598
Previous 7,719 40.43%
Holding current value
$222,819
Previous $533 Million 52.11%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$45.38 - $71.7 $141,630 - $223,775
-3,121 Reduced 40.43%
4,598 $255 Million
Q2 2025

Aug 13, 2025

BUY
$58.08 - $81.05 $28,865 - $40,281
497 Added 6.88%
7,719 $533 Million
Q1 2025

May 13, 2025

BUY
$69.3 - $90.95 $500,484 - $656,840
7,222 New
7,222 $501 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Vest Gen Advisors, LLC Portfolio

Follow Vest Gen Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vest Gen Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vest Gen Advisors, LLC with notifications on news.